Medicrea GroupFiles to FDA for Approval of 3D-Printed Titanium Interbody Devices

Published by , January 10, 2017 2:48 am

(YahooFinance) The Medicrea Group, a leader pioneering the development and manufacture of personalized analytical services and implant solutions for the treatment of complex spinal conditions, has announced the filing of its 510(k) submission to the U.S. Food and Drug Administration (FDA) for approval of the Company’s 3D-printed Titanium interbody devices, with compatible UNiD™ Lab personalized surgical planning and analytical services.
Denys SOURNAC, President and CEO, stated, “With in-house additive manufacturing capabilities and FDA clearance anticipated before the end of 2017, Medicrea’s platform of 3D-printed Titanium devices will enable the Company to provide an even more robust and comprehensive solution for patients and surgeons.”

Tags: , ,